Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

Jan-29	Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion LLY Benzinga
Jan-29	Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product GUTS -68.04% Benzinga
Jan-29	Thermo Fisher Scientific Discloses How Much Clario Deal Could Add To Its EPS TMO Benzinga
Jan-29	Steel Partners Targets InMode, Citing Stock Underperformance INMD +5.95% Benzinga
Jan-29	Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination NEOG Benzinga
Jan-29	FDA Accepts Summit's Lung Cancer Drug Application, Review Underway SMMT MRK ONC Benzinga
Jan-29	AstraZeneca Bets Big On China With Massive $15 Billion Investment AZN Benzinga
Jan-29	Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control TAK Benzinga
Jan-29	Sanofi Warns Dupixent Is Too Big To Replace As Patent Clock Ticks SNY Benzinga
Jan-28	Halozyme Therapeutics Projects Sustained Growth Well Into 2040 HALO Benzinga
Jan-28	Hospital Operator HCA Healthcare Is Set For Solid Growth, Higher Value-Analyst UHS HCA ARDT Benzinga
Jan-28	FDA Clinical Hold Knocks REGENXBIO Stock RGNX Benzinga
Jan-28	Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook TEVA Benzinga
Jan-28	CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis CALC Benzinga
Jan-28	US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026 ELV Benzinga
Jan-28	Danaher Expects Gradual Improvement In End-Market Conditions DHR Benzinga
Jan-28	EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal FEED Benzinga
Jan-28	Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst ASTH ALHC AGL Benzinga
Jan-28	Cardiff Oncology Stock Plunges After Sudden Leadership Change, Narrowed Trial Focus CRDF Benzinga
Jan-28	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle TAK PFE NVS LLY JNJ +4 More Benzinga
Jan-27	Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug PFE ACRS Benzinga
Jan-27	Intellia Moves Forward As FDA Removes Trial Hold For Rare Disorder NTLA Benzinga
Jan-27	Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication MESO Benzinga
Jan-27	Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trial MRK KZIA Benzinga
Jan-27	Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments GNTA Benzinga
Jan-27	$100 Billion Market Cap Hospital Operator HCA Healthcare To Buy Back Stock Worth $10 Billion HCA Benzinga
Jan-27	UnitedHealth's Revenue Outlook, Medicare Shock Spook Investors UNH Benzinga
Jan-27	Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling UNH MOH HUM ELV CVS +2 More Benzinga
Jan-27	Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight NVO LLY Benzinga
Jan-26	Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag SNY PFE NVS COGT Benzinga
Jan-26	Sarepta Says Elevidys Slows Duchenne Progression After Three Years SRPT Benzinga
Jan-26	United Therapeutics Reports Early Success For External Liver Support In Acute Failure XMHQ UTHR PINK FXH Benzinga
Jan-26	Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? RVMD MRK ERAS Benzinga
Jan-26	Revolution Medicines Stock Sinks After Merck Deal Talks Collapse RVMD MRK ABBV Benzinga
Jan-23	FTC Delays Drug Middlemen Case While Talks Move Forward UNH CVS CI Benzinga
Jan-23	Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain ABT Benzinga
Jan-23	Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research PFE Benzinga
Jan-23	CVRx Kicks Off One Of The Largest Heart Device Trials In History CVRX Benzinga
Jan-23	FDA Issues Alert For Integra Wound Care Products Over Infection Fears IART Benzinga
Jan-23	ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software CLPT Benzinga
Jan-23	Novartis Positions US Strategy As Defense Against Rising Trade Levies NVS Benzinga
Jan-23	Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase XBI PCVX MEDI Benzinga
Jan-23	Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It NVO LLY GPCR Benzinga
Jan-23	Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies SNY Benzinga
Jan-22	Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million MRK JANX BMY Benzinga
Jan-22	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer PTH PFE MRK LFSC GH +1 More Benzinga
Jan-22	Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half HOTH Benzinga
Jan-22	Axogen Prices Upsized $124 Million Stock Offering XHE HTEC AXGN Benzinga
Jan-22	Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps CORT Benzinga
Jan-22	Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints EXAS ABT Benzinga
Jan-22	UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates UNH ELV CVS CI Benzinga
Jan-21	Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure TLX Benzinga
Jan-21	Apellis Valuation Ignores Empaveli Potential, Says Analyst NVS APLS Benzinga
Jan-21	Nano-Cap Brand Engagement Network Stock Rallies As Africa AI Deal Fuels Investor Buzz BNAI Benzinga
Jan-21	Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface PEN MDT BSX Benzinga
Jan-21	Johnson & Johnson Talc Plaintiffs Clear Key Expert Testimony Hurdle JNJ Benzinga
Jan-21	Nano-Cap Smart Logistics Stock Spikes As Trading Volume Soars SLGB Benzinga
Jan-21	FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer ALBT Benzinga
Jan-21	Qiagen Explores Possible Sale After New Buyer Talks: Report TMO QGEN BIO Benzinga
Jan-21	Johnson & Johnson Expects 2026 Sales To Hit Almost $100 Billion JNJ Benzinga
Jan-21	Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences SPRB BMY AZN Benzinga
Jan-20	Moderna-Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma MRNA MRK Benzinga
Jan-20	Valneva Steps Back From US Approval Bid For Chikungunya Vaccine VALN PFE Benzinga
Jan-20	Corvus Stock Spikes On Heels Of Strong Eczema Study Results CRVS Benzinga
Jan-20	FDA Talks Set Path For Expanded Use For ImmunityBio's Anktiva In Bladder Cancer IBRX Benzinga
Jan-20	Genmab Lymphoma Study Misses Key Target, Analyst Still Sees Upside GMAB ABBV Benzinga
Jan-20	FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain MESO Benzinga
Jan-20	Illumina Gets Medicare Boost for Cancer Test, Shares Climb XMHQ ROBO ILMN FBT Benzinga
Jan-20	Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool MSFT BMY Benzinga
Jan-20	AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach AZN Benzinga
Jan-20	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report ROIV OGN MRK Benzinga
Jan-20	GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough RAPT PFE GSK Benzinga
Jan-16	Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action IRON Benzinga
Jan-16	Venus Concept Stock Explodes Over 500% After Major Investor Takes Control VERO Benzinga
Jan-16	ImmunityBio Stock Soars On Cancer Trial Progress, FDA Timeline IBRX Benzinga
Jan-16	Profusa Stock Spikes As Lumee System Targets Research Market PFSA Benzinga
Jan-16	Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data NVO Benzinga
Jan-16	PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push PRFX Benzinga
Jan-16	Ford Explores BYD Battery Partnership As Hybrid Strategy Accelerates: Report TSLA GM F Benzinga
Jan-15	Ocugen's Early Gene Therapy Data Shows 46% Drop In Vision Damage OCGN Benzinga
Jan-15	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence XHE STAA ALC Benzinga
Jan-15	ImmunityBio Clocks 700% Revenue Surge In 2025 From Lead Bladder Cancer Drug IBRX Benzinga
Jan-15	Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 TCAF IHI EQTY BDX Benzinga
Jan-15	Johnson & Johnson Drug Slows Blood Cancer, Extends Survival In Pretreated Patients JNJ Benzinga
Jan-15	OS Therapies Bone Cancer Trial Data Strengthens FDA Case OSTX OCGN Benzinga
Jan-15	Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments NVO LLY GPCR Benzinga
Jan-15	Morgan Stanley Sees 2026 IPO Wave, CFO Flags Bigger Pipeline, Broader Dealmaking MS Benzinga
Jan-15	FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks SNY MRK LLY IRON Benzinga
Jan-15	EXCLUSIVE: GT Biopharma Plans 2026 Trial For New Cancer Treatment GTBP Benzinga
Jan-14	iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst IRTC Benzinga
Jan-14	Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses AMGN Benzinga
Jan-14	Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum ENLV Benzinga
Jan-14	Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges UNH PSTV Benzinga
Jan-14	UnitedHealth Pilot Aims To Cut Rural Hospital Payment Delays In Half XLV UNH EAGL Benzinga
Jan-14	Wells Fargo CEO Says Bank Can Compete On 'More Level Playing Field' In 2026 WFC Benzinga
Jan-14	EXCLUSIVE: Micro-Cap ENvue Medical Launches OTC Reusable Syringes For Feeding, Medication Delivery FEED Benzinga
Jan-14	EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment SCNX Benzinga
Jan-14	Travere Stock Slips After FDA Delays Review Of Key Kidney Drug TVTX LFSC FYX FYC Benzinga
Jan-14	What's Going On With BriaCell Therapeutics Stock Wednesday? BCTX Benzinga
Jan-14	Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook RVTY MDEV Benzinga

Vandana Singh

Recent Articles by Vandana Singh

Upgrade your FINVIZ experience